Prevention of letrozole induced bone loss using risedronate in postmenopausal women with hormone receptor positive breast cancer: A multicenter randomized clinical trial

被引：0
|
作者：
Kadoya, T.
Masumoto, N.
Shigematsu, H.
Emi, A.
Kajitani, K.
Kobayashi, Y.
Funakoshi, M.
Kawabuchi, Y.
Ohara, M.
Matsuura, K.
Noma, M.
Sasada, T.
Okada, M.
机构：
[1] Hiroshima Univ, Res Inst Radiat Biol & Med, Hiroshima, Japan
[2] Hiroshima City Asa Citizens Hosp, Hiroshima, Japan
[3] Hiroshima Gen Hosp, Hatsukaichi, Japan
[4] Hiroshima Prefectural Hosp, Hiroshima, Japan
[5] Onomichi Gen Hosp, Onomichi, Japan
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P1-15-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-15-03
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial
    Greenspan, S. L.
    Vujevich, K. T.
    Brufsky, A.
    Lembersky, B. C.
    van Londen, G. J.
    Jankowitz, R. C.
    Puhalla, S. L.
    Rastogi, P.
    Perera, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 (06) : 1857 - 1864
  • [2] Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial
    S. L. Greenspan
    K. T. Vujevich
    A. Brufsky
    B. C. Lembersky
    G. J. van Londen
    R. C. Jankowitz
    S. L. Puhalla
    P. Rastogi
    S. Perera
    [J]. Osteoporosis International, 2015, 26 : 1857 - 1864
  • [3] MANAGEMENT OF AROMATASE INHIBITORS-INDUCED BONE LOSS IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE BREAST CANCER
    Karalilova, R.
    Batalov, A.
    Batalov, Z.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S381 - S381
  • [4] The EXpand Study - Effect of Zoledronic Acid on Prevention of Bone Loss, During Extended Adjuvant Therapy With Letrozole in Postmenopausal Women With Primary Hormone Receptor Positive Breast Cancer Compared to Letrozole Alone
    Hellriegel, M.
    Mueller, M.
    Reimer, T.
    Baerens, D. T.
    von der Assen, A.
    Hackmann, J.
    Schmidt, K.
    Baier-Ebert, M.
    Spall, T.
    Emons, G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S390 - S390
  • [5] Zoledronic acid in the prevention of cancer treatment-induced bone loss in postmenopausal women receiving letrozole as adjuvant therapy for early breast cancer
    不详
    [J]. BREAST, 2005, 14 : S44 - S44
  • [6] Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA Trial
    Goodwin, Pamela J.
    Segal, Roanne J.
    Vallis, Michael
    Ligibel, Jennifer A.
    Pond, Gregory R.
    Robidoux, Andre
    Blackburn, George L.
    Findlay, Brian
    Gralow, Julie R.
    Mukherjee, Som
    Levine, Mark
    Pritchard, Kathleen I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (21) : 2231 - +
  • [7] Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer
    Brufsky, Adam
    Harker, W. Graydon
    Beck, J. Thaddeus
    Carroll, Robert
    Tan-Chiu, Elizabeth
    Seidler, Christopher
    Hohneker, John
    Lacerna, Leo
    Petrone, Stephanie
    Perez, Edith A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 829 - 836
  • [8] Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial
    Hooper, MJ
    Ebeling, PR
    Roberts, AP
    Graham, JJ
    Nicholson, GC
    D'Emden, M
    Ernst, TF
    Wenderoth, D
    [J]. CLIMACTERIC, 2005, 8 (03) : 251 - 262
  • [9] Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: A randomized controlled trial
    El-Hajj Fuleihan, G
    Salamoun, M
    Abou Mourad, Y
    Chehal, A
    Salem, Z
    Mahfoud, Z
    Shamseddine, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06): : 3209 - 3214
  • [10] Daily risedronate prevents bone loss in osteopenic, postmenopausal women:: A 2-year multicenter trial in europe
    Valmaki, M.
    Heikkinen, J.
    Munoz-Torres, M.
    Mulder, H.
    Ofjord, E. S.
    Toss, G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S60 - S61
12345